Marong Fang Selected Research

N- (4- ((6,7- dimethoxy- 4- quinolyl)oxy)- 2- methoxyphenyl)- N'- (1- (1,3- thiazole- 2- yl)ethyl)urea

1/2020	Inhibited CSF1R Alleviates Ischemia Injury via Inhibition of Microglia M1 Polarization and NLRP3 Pathway.
1/2020	Combinational Pretreatment of Colony-Stimulating Factor 1 Receptor Inhibitor and Triptolide Upregulates BDNF-Akt and Autophagic Pathways to Improve Cerebral Ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marong Fang Research Topics

Disease

12	Brain Ischemia (Cerebral Ischemia) 01/2021 - 04/2012
11	Inflammation (Inflammations) 09/2022 - 01/2011
8	Stroke (Strokes) 09/2022 - 01/2014
8	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 07/2005
7	Spinal Cord Injuries (Spinal Cord Injury) 03/2020 - 01/2011
5	Reperfusion Injury 01/2018 - 04/2012
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 07/2012
4	Infarction (Infarctions) 01/2020 - 01/2015
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018 - 01/2015
4	Gliosis 01/2016 - 12/2009
3	Ischemic Stroke 09/2022 - 01/2020
3	Neuroinflammatory Diseases 01/2022 - 01/2013
3	Ischemia 01/2021 - 01/2014
3	Brain Injuries (Brain Injury) 01/2021 - 01/2014
3	Amyloid Plaque 10/2017 - 12/2009
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2013 - 01/2013
2	Hypoxia (Hypoxemia) 09/2022 - 01/2009
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 08/2011
2	Mental Disorders (Mental Disorder) 01/2022 - 01/2019
2	Postpartum Depression (Post-Natal Depression) 01/2018 - 10/2017
2	Memory Disorders (Memory Loss) 04/2012 - 09/2010
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022
1	Hyperalgesia 01/2022
1	Hyperplasia 01/2022
1	Infections 01/2021
1	Neurodevelopmental Disorders 12/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Pheochromocytoma 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Mood Disorders (Mood Disorder) 01/2018
1	Brain Infarction 02/2016
1	Cognitive Dysfunction 01/2016
1	Cerebral Infarction 01/2016
1	Brain Edema (Cerebral Edema) 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016

Drug/Important Bio-Agent (IBA)

12	Neuroprotective AgentsIBA 09/2022 - 01/2011
10	Proteins (Proteins, Gene)FDA Link 09/2022 - 10/2006
6	triptolideIBA 03/2020 - 01/2015
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 01/2014
4	Amyloid (Amyloid Fibrils)IBA 10/2017 - 12/2009
3	5-dehydro-3-deoxy-D-arabino-heptulosonic acid-7-phosphate (DAHP)IBA 01/2018 - 01/2015
3	CytokinesIBA 01/2014 - 04/2012
3	C16 peptideIBA 07/2013 - 01/2013
2	Carisoprodol (Soma)FDA LinkGeneric 09/2022 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022 - 01/2014
2	Endothelin-1 (Endothelin 1)IBA 09/2022 - 01/2021
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2014
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2022 - 09/2010
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2022 - 01/2015
2	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 01/2017
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2018
2	ChloridesIBA 01/2020 - 01/2015
2	N- (4- ((6,7- dimethoxy- 4- quinolyl)oxy)- 2- methoxyphenyl)- N'- (1- (1,3- thiazole- 2- yl)ethyl)ureaIBA 01/2020 - 01/2020
2	Macrophage Colony-Stimulating FactorIBA 01/2020 - 01/2020
2	GlucocorticoidsIBA 01/2019 - 01/2014
2	Serotonin ReceptorsIBA 01/2019 - 07/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 09/2010
2	Tuberculin (PPD)IBA 01/2018 - 10/2017
2	EnzymesIBA 10/2017 - 02/2012
2	IntegrinsIBA 07/2013 - 01/2013
2	Peptides (Polypeptides)IBA 01/2013 - 08/2011
2	MicroRNAs (MicroRNA)IBA 08/2011 - 03/2009
1	Transcription Factors (Transcription Factor)IBA 09/2022
1	ApolipoproteinsIBA 02/2022
1	ParvalbuminsIBA 01/2022
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2022
1	gamma-Aminobutyric Acid (GABA)IBA 01/2022
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2022
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2021
1	oxalylglycineIBA 01/2021
1	AcriflavineIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Hypoxia-Inducible Factor 1IBA 01/2021
1	Claudin-1IBA 01/2021
1	OccludinIBA 01/2021
1	InflammasomesIBA 01/2020
1	Caspase 1 (ICE Protease)IBA 01/2020
1	ResveratrolIBA 03/2019
1	Sirtuin 1IBA 01/2019
1	GuanosineIBA 01/2018
1	CurcuminIBA 01/2018
1	Methylprednisolone FDA LinkGeneric 01/2018
1	triphenyltetrazoliumIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2017
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2016
1	Progesterone FDA LinkGeneric 01/2016
1	Hormones (Hormone)IBA 01/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2016
1	Cholinergic Agents (Cholinergics)IBA 01/2016

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2014
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2016